Bicara Therapeutics Inc.

Bicara Therapeutics Inc.

Biotechnology • Healthcare • Boston, MA, United States • BCAX (NGM)

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.

617 468 4219 116 Huntington Avenue, Boston, MA 02116, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

The Bull Case For Bicara Therapeutics (BCAX) Could Change Following Dual Inclusion In Major Biotech Indices - Yahoo Finance
Yahoo Finance • Dec 22
Bicara Therapeutics (NASDAQ:BCAX) Stock Price Up 3.9% - Still a Buy? - MarketBeat
MarketBeat • Dec 31
Mizuho initiates Bicara Therapeutics stock coverage with Neutral rating By Investing.com - Investing.com Nigeria
Investing.com Nigeria • Dec 17
Bicara Therapeutics Reports Promising Phase 1b Data - TipRanks
TipRanks • Dec 8
Bicara Therapeutics: Intriguing Opportunity Given Rival Merus' $8B Buyout (NASDAQ:BCAX) - Seeking Alpha
Seeking Alpha • Nov 25

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Bicara Therapeutics Inc. had layoffs?
No layoff events have been recorded for Bicara Therapeutics Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Bicara Therapeutics Inc. have?
Bicara Therapeutics Inc. has approximately 55 employees.
What industry is Bicara Therapeutics Inc. in?
Bicara Therapeutics Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Bicara Therapeutics Inc. a publicly traded company?
Yes, Bicara Therapeutics Inc. is publicly traded under the ticker symbol BCAX on the NGM. The company has a market capitalization of approximately $0.92 billion.
Where is Bicara Therapeutics Inc. headquartered?
Bicara Therapeutics Inc. is headquartered in Boston, MA, United States at 116 Huntington Avenue, Boston, MA 02116, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.